ArticleThe Journal of international medical research2020

Reduction of pericardial effusion in advanced non-small cell lung cancer patients with KRAS, TP53, and MET mutation treated with nivolumab.

Zhihui Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.